Overweight individuals with hepatic steatosis displayed stronger leptin immunoreactivity in the liver compared to overweight men without histopathological changes in the organ, whereas the intensity of reaction against visfatin and chemerin was weaker in overweight men with fatty liver compared to overweight subjects with normal hepatic structure. This evidence concerns the gene NAMPT and fatty liver disease.